Works matching IS 22963774 AND DT 2022 AND VI 9 AND IP 1
Results: 6
Sequential Treatment Strategy Using Fluoropyrimidine plus Bevacizumab Followed by Oxaliplatin for Metastatic Colorectal Cancer: A Phase II Study (OGSG 1107).
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 27, doi. 10.1159/000522610
- By:
- Publication type:
- Article
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction over 32-Month Follow-Up.
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 12, doi. 10.1159/000522363
- By:
- Publication type:
- Article
Trends of Clinical Outcomes of Patients with Advanced Hepatocellular Carcinoma Treated with First-Line Sorafenib in Randomized Controlled Trials.
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 19, doi. 10.1159/000521625
- By:
- Publication type:
- Article
Gallbladder Neuroendocrine Tumors: Is There a Need for a Specific Approach?
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 5, doi. 10.1159/000520988
- By:
- Publication type:
- Article
Lower Extremity Varicose Veins: An Unusual Presentation of Small Bowel Leiomyosarcoma.
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 1, doi. 10.1159/000520802
- By:
- Publication type:
- Article
Thyroid Disease and Hepatocellular Carcinoma Survival: A Danish Nationwide Cohort Study.
- Published in:
- Gastrointestinal Tumors, 2022, v. 9, n. 1, p. 37, doi. 10.1159/000520679
- By:
- Publication type:
- Article